LncRNA HCP5 as a potential therapeutic target and prognostic biomarker for various cancers: a meta‑analysis and bioinformatics analysis
Abstract Background Accumulating studies indicated that dysregulated long non-coding RNA human histocompatibility leukocyte antigen (HLA) Complex P5 (HCP5) may functions as an potential prognostic predictor in multiple cancers. This meta-analysis was performed to systematically collect studies and c...
Main Authors: | Shao-pu Hu, Meng-xue Ge, Lei Gao, Min Jiang, Kai-wen Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-12-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-021-02404-x |
Similar Items
-
LncRNA HCP5-Encoded Protein Regulates Ferroptosis to Promote the Progression of Triple-Negative Breast Cancer
by: Xiao Tong, et al.
Published: (2023-03-01) -
Exploration of the involvement of LncRNA in HIV-associated encephalitis using bioinformatics
by: Diangeng Li, et al.
Published: (2018-10-01) -
LINC00958 may be a new prognostic biomarker in various cancers: A meta-analysis and bioinformatics analysis
by: Helin Zhang, et al.
Published: (2022-11-01) -
LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis
by: Wei Yang, et al.
Published: (2021-12-01) -
HOXA-AS2 may be a potential prognostic biomarker in human cancers: A meta-analysis and bioinformatics analysis
by: Fan Zhang, et al.
Published: (2022-11-01)